Brief: Engene Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
30/12/2024 21:24
Dec 30 (Reuters) - enGene Holdings Inc ENGN.O :
* ENGENE REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE
5635(C)(4)
Source text: ID:nBw4SFTRNa
Further company coverage: ENGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on enGene Therapeutics
See all newsenGene Therapeutics Inc. reports results for the quarter ended July 31 - Earnings Summary
enGene Therapeutics Inc. expected to post a loss of 43 cents a share - Earnings Preview
Brief: Engene Reports Second Quarter 2026 Financial Results And Provides Business Update
enGene Therapeutics Inc expected to post a loss of 47 cents a share - Earnings Preview
Brief: Engene Holdings Inc - To Change Name To Engene Therapeutics Inc. Effective April 8, 2026